- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-pentamer
- Ligands
- 5 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 5 x I33: 7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide(Non-covalent)
I33.6: 14 residues within 4Å:- Chain A: Y.115, W.171, Y.210, E.211, C.212, Y.217
- Chain B: S.56, L.57, S.58, W.77, L.78, Q.79, L.141, D.186
8 PLIP interactions:4 interactions with chain B, 4 interactions with chain A- Hydrophobic interactions: B:W.77, B:W.77, B:Q.79, B:L.141, A:W.171, A:Y.210
- Hydrogen bonds: A:E.211, A:C.212
I33.9: 14 residues within 4Å:- Chain B: Y.115, W.171, Y.210, E.211, C.212, Y.217
- Chain C: S.56, L.57, S.58, W.77, L.78, Q.79, L.141, D.186
9 PLIP interactions:4 interactions with chain B, 5 interactions with chain C- Hydrophobic interactions: B:W.171, B:Y.210, C:W.77, C:W.77, C:W.77, C:Q.79, C:L.141
- Hydrogen bonds: B:E.211, B:C.212
I33.12: 14 residues within 4Å:- Chain C: Y.115, W.171, Y.210, E.211, C.212, Y.217
- Chain D: S.56, L.57, S.58, W.77, L.78, Q.79, L.141, D.186
9 PLIP interactions:4 interactions with chain C, 5 interactions with chain D- Hydrophobic interactions: C:W.171, C:Y.210, D:W.77, D:W.77, D:W.77, D:Q.79, D:L.141
- Hydrogen bonds: C:E.211, C:C.212
I33.15: 14 residues within 4Å:- Chain D: Y.115, W.171, Y.210, E.211, C.212, Y.217
- Chain E: S.56, L.57, S.58, W.77, L.78, Q.79, L.141, D.186
9 PLIP interactions:5 interactions with chain E, 4 interactions with chain D- Hydrophobic interactions: E:W.77, E:W.77, E:W.77, E:Q.79, E:L.141, D:W.171, D:Y.210
- Hydrogen bonds: D:E.211, D:C.212
I33.18: 14 residues within 4Å:- Chain A: S.56, L.57, S.58, W.77, L.78, Q.79, L.141, D.186
- Chain E: Y.115, W.171, Y.210, E.211, C.212, Y.217
9 PLIP interactions:4 interactions with chain E, 5 interactions with chain A- Hydrophobic interactions: E:W.171, E:Y.210, A:W.77, A:W.77, A:W.77, A:Q.79, A:L.141
- Hydrogen bonds: E:E.211, E:C.212
- 5 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.7: 2 residues within 4Å:- Chain A: N.46, S.48
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:N.46, A:S.48, A:Q.49
NAG.10: 2 residues within 4Å:- Chain B: N.46, S.48
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:N.46, B:S.48, B:Q.49
NAG.13: 2 residues within 4Å:- Chain C: N.46, S.48
3 PLIP interactions:3 interactions with chain C- Hydrogen bonds: C:N.46, C:S.48, C:Q.49
NAG.16: 2 residues within 4Å:- Chain D: N.46, S.48
3 PLIP interactions:3 interactions with chain D- Hydrogen bonds: D:N.46, D:S.48, D:Q.49
NAG.19: 2 residues within 4Å:- Chain E: N.46, S.48
3 PLIP interactions:3 interactions with chain E- Hydrogen bonds: E:N.46, E:S.48, E:Q.49
- 5 x CLR: CHOLESTEROL(Non-covalent)
CLR.8: 9 residues within 4Å:- Chain A: I.313, Y.317, P.328, W.330, T.331, I.334, V.467, C.471, A.474
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:I.313, A:W.330, A:I.334, A:V.467, A:A.474
CLR.11: 9 residues within 4Å:- Chain B: I.313, Y.317, P.328, W.330, T.331, I.334, V.467, C.471, A.474
5 PLIP interactions:5 interactions with chain B- Hydrophobic interactions: B:I.313, B:W.330, B:I.334, B:V.467, B:A.474
CLR.14: 9 residues within 4Å:- Chain C: I.313, Y.317, P.328, W.330, T.331, I.334, V.467, C.471, A.474
5 PLIP interactions:5 interactions with chain C- Hydrophobic interactions: C:I.313, C:W.330, C:I.334, C:V.467, C:A.474
CLR.17: 9 residues within 4Å:- Chain D: I.313, Y.317, P.328, W.330, T.331, I.334, V.467, C.471, A.474
5 PLIP interactions:5 interactions with chain D- Hydrophobic interactions: D:I.313, D:W.330, D:I.334, D:V.467, D:A.474
CLR.20: 9 residues within 4Å:- Chain E: I.313, Y.317, P.328, W.330, T.331, I.334, V.467, C.471, A.474
5 PLIP interactions:5 interactions with chain E- Hydrophobic interactions: E:I.313, E:W.330, E:I.334, E:V.467, E:A.474
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhao, Y. et al., Structural basis of human alpha 7 nicotinic acetylcholine receptor activation. Cell Res. (2021)
- Release Date
- 2021-05-19
- Peptides
- Neuronal acetylcholine receptor subunit alpha-7: ABCDE
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
E - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-pentamer
- Ligands
- 5 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 5 x I33: 7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide(Non-covalent)
- 5 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 5 x CLR: CHOLESTEROL(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhao, Y. et al., Structural basis of human alpha 7 nicotinic acetylcholine receptor activation. Cell Res. (2021)
- Release Date
- 2021-05-19
- Peptides
- Neuronal acetylcholine receptor subunit alpha-7: ABCDE
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
E - Membrane
-
We predict this structure to be a membrane protein.